Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Sodium, potassium adenosine triphosphatase as a potential target of the anti-tuberculosis agents, clofazimine and bedaquiline
Dissertation (MSc (Medical Immunology))--University of Pretoria, 2023.
Saved in:
| Other Authors: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
University of Pretoria
2024
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867613592864423936 |
|---|---|
| access_status_str | Open Access |
| author2 | Cholo, Moloko C. |
| author_browse | Cholo, Moloko C. |
| author_facet | Cholo, Moloko C. |
| collection | Thesis |
| dc_rights_str_mv | © 2023 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria. |
| description | Dissertation (MSc (Medical Immunology))--University of Pretoria, 2023. |
| format | Thesis |
| id | oai:repository.up.ac.za:2263/94997 |
| institution | University of Pretoria (South Africa) |
| language | English |
| last_indexed | 2026-06-10T12:38:35.948Z |
| license_str | Other — see source repository |
| provenance_str_mv | Harvested via OAI-PMH from UPSpace — University of Pretoria Institutional Repository |
| publishDate | 2024 |
| publishDateRange | 2024 |
| publishDateSort | 2024 |
| publisher | University of Pretoria |
| publisherStr | University of Pretoria |
| record_format | dspace |
| source_str | UPSpace — University of Pretoria Institutional Repository |
| spelling | oai:repository.up.ac.za:2263/94997 Sodium, potassium adenosine triphosphatase as a potential target of the anti-tuberculosis agents, clofazimine and bedaquiline Cholo, Moloko C. u11283026@tuks.co.za Steel, Helen Carolyn Mmakola, Khomotso Madimetsa Shelboy UCTD Tuberculosis Mycobacterium tuberculosis (MTB) Sodium Potassium-adenosine triphosphatase Adenosine triphosphate Clofazimine Bedaquiline Drug-resistant tuberculosis (DR-TB) Mononuclear leucocytes Cardiomyocytes Dissertation (MSc (Medical Immunology))--University of Pretoria, 2023. BACKGROUND: Tuberculosis (TB) is a disease caused by the acid-fast bacterium, Mycobacterium tuberculosis (M. tuberculosis). It is currently the leading cause of morbidity and mortality worldwide due to a single infectious agent. One of the main contributing factors to the burden of the disease is an alarming increase in the number of drug-resistant tuberculosis (DR-TB) cases. Recently, an efficient chemotherapeutic regimen, containing two second-line drugs, namely clofazimine (CFZ) and bedaquiline (BDQ), has been introduced. The use of these antibiotics has been associated with prolongation of the cardiac QT interval (this is measurement of the heart rate shown on the electrocardiogram), which leads to fatal cardiac arrhythmias. However, the mechanism by which these agents cause cardiac arrhythmia remains unknown. In this context, CFZ has been reported to inhibit the activity of the sodium, potassium-adenosine triphosphatase (Na+,K+-ATPase) enzyme in T lymphocytes, while the effects of BDQ on Na+,K+-ATPase have, to date, been unexplored. Importantly, however, both CFZ and BDQ target K+ channels in human mammalian cells including those of the mononuclear leukocytes (MNLs) and cardiac muscle cells (cardiomyocytes: CMs). Despite this, the effect of these two antibiotics on Na+,K+-ATPase of cardiomyocytes has not been described. AIM AND OBJECTIVES: The aim of the current study was to evaluate the effects of CFZ and BDQ on the activity of Na+,K+-ATPase of MNLs and rat cardiomyocytes (RCMs), by determining the activity of Na+,K+-ATPase via inorganic phosphate (Pi) concentration measurements, quantification of intracellular ATP levels and cellular viability. METHODS: The MNLs were isolated from healthy adult volunteers while the RCMs were obtained commercially. The MNLs and RCMs were treated with varying concentrations of CFZ and BDQ individually and in combinations (0.15 - 5 mg/L). Thereafter, Pi concentrations (using a Na+,K+-ATPase activity assay), ATP levels (using a colorimetric ATP assay) and number of viable cells (measured flow cytometrically) were determined. RESULTS: All antibiotic assays demonstrated inhibition in Na+,K+-ATPase activity in a dose-response related manner. Clofazimine was found to have the greatest inhibitory effect on the Na+,K+-ATPase activity in MNLs followed by BDQ while the effect was attenuated when the two antibiotics were used in combination. However, in RCMs, the greatest inhibitory effect of the antibiotics was demonstrated by combinations of the two antibiotics, followed by CFZ and BDQ alone, which however, demonstrated a comparable effect. In both cell lines, the inhibitory effect on Na+,K+-ATPase activity by the antibiotics was associated with an increase in ATP concentrations. Additionally, these effects were followed by a decline in cellular viability in the case of MNLs while a slight increase in cellular viability was observed in the RCMs for all antibiotic treatments. However, there was a decrease in cellular viability of the RCMs when the antibiotics were used in combination at their highest concentration of 5 mg/L. CONCLUSION: The results of the current study illustrate the implication of the Na+,K+-ATPase in the beneficial effects of CFZ and BDQ on the immunomodulatory roles of the MNLs while, importantly, demonstrating the potentially detrimental effects of these antibiotics, especially BDQ and, more notably, when the two antibiotics are used in combination, on the viability of the cardiomyocytes via targeting the Na+,K+-ATPase pump. This may contribute to the risk on individuals administered these drugs of developing cardiac arrhythmia. National Research Foundation National Health Laboratory Services Postgraduate Office, University of Pretoria Department of Immunology, University of Pretoria Department of Medical Microbiology, University of Pretoria BioMerieux company, South Africa Immunology MSc (Medical Immunology) Unrestricted Faculty of Health Sciences SDG-03:Good heatlh and well-being 2024-02-29T08:34:27Z 2024-02-29T08:34:27Z 2024-05-03 2023 Dissertation * S2024 http://hdl.handle.net/2263/94997 https://doi.org/10.25403/UPresearchdata.19029833.v2 en © 2023 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria. application/pdf University of Pretoria |
| spellingShingle | UCTD Tuberculosis Mycobacterium tuberculosis (MTB) Sodium Potassium-adenosine triphosphatase Adenosine triphosphate Clofazimine Bedaquiline Drug-resistant tuberculosis (DR-TB) Mononuclear leucocytes Cardiomyocytes Sodium, potassium adenosine triphosphatase as a potential target of the anti-tuberculosis agents, clofazimine and bedaquiline |
| title | Sodium, potassium adenosine triphosphatase as a potential target of the anti-tuberculosis agents, clofazimine and bedaquiline |
| title_full | Sodium, potassium adenosine triphosphatase as a potential target of the anti-tuberculosis agents, clofazimine and bedaquiline |
| title_fullStr | Sodium, potassium adenosine triphosphatase as a potential target of the anti-tuberculosis agents, clofazimine and bedaquiline |
| title_full_unstemmed | Sodium, potassium adenosine triphosphatase as a potential target of the anti-tuberculosis agents, clofazimine and bedaquiline |
| title_short | Sodium, potassium adenosine triphosphatase as a potential target of the anti-tuberculosis agents, clofazimine and bedaquiline |
| title_sort | sodium potassium adenosine triphosphatase as a potential target of the anti tuberculosis agents clofazimine and bedaquiline |
| topic | UCTD Tuberculosis Mycobacterium tuberculosis (MTB) Sodium Potassium-adenosine triphosphatase Adenosine triphosphate Clofazimine Bedaquiline Drug-resistant tuberculosis (DR-TB) Mononuclear leucocytes Cardiomyocytes |
| url | http://hdl.handle.net/2263/94997 https://doi.org/10.25403/UPresearchdata.19029833.v2 |